Found: 14
Select item for more details and to access through your institution.
Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone.
- Published in:
- Clinical & Translational Oncology, 2021, v. 23, n. 10, p. 2171, doi. 10.1007/s12094-021-02625-6
- By:
- Publication type:
- Article
A New Scoring System for Predicting Mortality in Hematological Malignancies with Sepsis: A Derivation and Validation Study.
- Published in:
- Cancer Management & Research, 2023, v. 15, p. 1073, doi. 10.2147/CMAR.S428930
- By:
- Publication type:
- Article
Clinical Characteristics and Outcome Analysis for HLA Loss Patients Following Partially Mismatched Related Donor Transplantation Using HLA Chimerism for Loss of Heterozygosity Analysis by Next-Generation Sequencing.
- Published in:
- Cell Transplantation, 2022, v. 31, p. 1, doi. 10.1177/09636897221102902
- By:
- Publication type:
- Article
SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1269531
- By:
- Publication type:
- Article
Long-term efficacy and safety of arsenic trioxide for first-line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 1, p. 115, doi. 10.1002/cncr.27650
- By:
- Publication type:
- Article
Pharmacokinetics of cefoperazone/sulbactam in critically Ill thrombotic thrombocytopenic purpura patients undergoing therapeutic plasma exchange.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 8, p. 1232, doi. 10.1111/jcpt.13660
- By:
- Publication type:
- Article
Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Targeting FHL1 impairs cell proliferation and differentiation of acute myeloid leukemia cells.
- Published in:
- Biochemistry & Cell Biology, 2022, v. 100, n. 4, p. 301, doi. 10.1139/bcb-2021-0507
- By:
- Publication type:
- Article
Characteristics of arsenic species in cerebrospinal fluid (CSF) of acute promyelocytic leukaemia (APL) patients treated with arsenic trioxide plus mannitol.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 4020, doi. 10.1111/bcp.14804
- By:
- Publication type:
- Article
Effect of continuous venovenous haemodialysis on outcome and pharmacokinetics of arsenic species in a patient with acute promyelocytic leukaemia and acute kidney injury.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 4, p. 849, doi. 10.1111/bcp.13875
- By:
- Publication type:
- Article
Growth inhibition and suppression of the mTOR and Wnt/β-catenin pathways in T-acute lymphoblastic leukemia by rapamycin and MYCN depletion.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Single-Center Retrospective Clinical Evaluation of Venetoclax Combined with HMAs and Half-Dose CAG for Unfit or Refractory/Relapsed AML.
- Published in:
- OncoTargets & Therapy, 2023, v. 16, p. 409, doi. 10.2147/OTT.S405611
- By:
- Publication type:
- Article
MYCN is a novel oncogenic target in adult B‐ALL that activates the Wnt/β‐catenin pathway by suppressing DKK3.
- Published in:
- Journal of Cellular & Molecular Medicine, 2018, v. 22, n. 7, p. 3627, doi. 10.1111/jcmm.13644
- By:
- Publication type:
- Article
miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 12, p. 3357, doi. 10.1007/s00277-023-05441-w
- By:
- Publication type:
- Article